Insider Analysis From Jones Day: New Patent Approach Is Needed For Pharmaceutical Research In China
This article was originally published in PharmAsia News
Executive Summary
By Steven X. Cui, Ph.D., Jones Day, Beijing, and Tony Chen, Jones Day, Shanghai
You may also be interested in...
Lilly Sees Payoff In China By Boning Up On Tax And Patent Law
SAN FRANCISCO - Adept management of tax, patent and government relations issues particular to China can help Western pharmaceutical companies reap the benefits of working in the vast, developing market while avoiding pitfalls
Lilly Sees Payoff In China By Boning Up On Tax And Patent Law
SAN FRANCISCO - Adept management of tax, patent and government relations issues particular to China can help Western pharmaceutical companies reap the benefits of working in the vast, developing market while avoiding pitfalls
While Navigating Risks, WuXi To Benefit from Global Outsourcing
BEIJING - WuXi PharmaTech is positioning itself to ride the rising tides of global pharmaceutical outsourcing to strengthen its role as China's largest contract research organization, according to a WuXi executive and an independent analyst